Logo image of CULP

CULP INC (CULP) Stock Fundamental Analysis

NYSE:CULP - New York Stock Exchange, Inc. - US2302151053 - Common Stock - Currency: USD

4.17  0 (0%)

Fundamental Rating

1

CULP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CULP may be in some trouble as it scores bad on both profitability and health. CULP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CULP had negative earnings in the past year.
In the past year CULP has reported a negative cash flow from operations.
In the past 5 years CULP reported 4 times negative net income.
In multiple years CULP reported negative operating cash flow during the last 5 years.
CULP Yearly Net Income VS EBIT VS OCF VS FCFCULP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

CULP has a worse Return On Assets (-17.17%) than 85.42% of its industry peers.
With a Return On Equity value of -36.72%, CULP is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.17%
ROE -36.72%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-8.96%
ROE(3y)-18.73%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
CULP Yearly ROA, ROE, ROICCULP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

CULP's Gross Margin of 11.27% is on the low side compared to the rest of the industry. CULP is outperformed by 93.75% of its industry peers.
CULP's Gross Margin has declined in the last couple of years.
CULP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.3%
GM growth 5Y-6.23%
CULP Yearly Profit, Operating, Gross MarginsCULP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

CULP does not have a ROIC to compare to the WACC, probably because it is not profitable.
CULP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CULP has more shares outstanding
There is no outstanding debt for CULP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CULP Yearly Shares OutstandingCULP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CULP Yearly Total Debt VS Total AssetsCULP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.29 indicates that CULP is not a great score, but indicates only limited risk for bankruptcy at the moment.
CULP has a Altman-Z score of 2.29. This is in the lower half of the industry: CULP underperforms 70.83% of its industry peers.
CULP has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
CULP's Debt to Equity ratio of 0.09 is fine compared to the rest of the industry. CULP outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 2.29
ROIC/WACCN/A
WACC10.28%
CULP Yearly LT Debt VS Equity VS FCFCULP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.68 indicates that CULP should not have too much problems paying its short term obligations.
The Current ratio of CULP (1.68) is worse than 64.58% of its industry peers.
CULP has a Quick Ratio of 1.68. This is a bad value and indicates that CULP is not financially healthy enough and could expect problems in meeting its short term obligations.
CULP's Quick ratio of 0.72 is on the low side compared to the rest of the industry. CULP is outperformed by 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.72
CULP Yearly Current Assets VS Current LiabilitesCULP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

CULP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.09%.
CULP shows a decrease in Revenue. In the last year, the revenue decreased by -9.80%.
Measured over the past years, CULP shows a decrease in Revenue. The Revenue has been decreasing by -4.34% on average per year.
EPS 1Y (TTM)-65.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.92%
Revenue 1Y (TTM)-9.8%
Revenue growth 3Y-9.07%
Revenue growth 5Y-4.34%
Sales Q2Q%-13.51%

3.2 Future

The Earnings Per Share is expected to grow by 37.01% on average over the next years. This is a very strong growth
Based on estimates for the next years, CULP will show a small growth in Revenue. The Revenue will grow by 1.98% on average per year.
EPS Next Y6.58%
EPS Next 2Y46.06%
EPS Next 3Y37.01%
EPS Next 5YN/A
Revenue Next Year-3.81%
Revenue Next 2Y0.97%
Revenue Next 3Y1.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CULP Yearly Revenue VS EstimatesCULP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CULP Yearly EPS VS EstimatesCULP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CULP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 29.20, CULP can be considered very expensive at the moment.
62.50% of the companies in the same industry are cheaper than CULP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.17. CULP is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 29.2
CULP Price Earnings VS Forward Price EarningsCULP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CULP Per share dataCULP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CULP does not grow enough to justify the current Price/Earnings ratio.
CULP's earnings are expected to grow with 37.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.06%
EPS Next 3Y37.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CULP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CULP INC

NYSE:CULP (6/3/2025, 11:40:40 AM)

4.17

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)06-25 2025-06-25/amc
Inst Owners62.45%
Inst Owner Change0.36%
Ins Owners7.22%
Ins Owner Change2.83%
Market Cap52.38M
Analysts82.86
Price TargetN/A
Short Float %0.42%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.28%
Min EPS beat(2)-34.8%
Max EPS beat(2)-29.76%
EPS beat(4)1
Avg EPS beat(4)-14.2%
Min EPS beat(4)-34.8%
Max EPS beat(4)15.03%
EPS beat(8)4
Avg EPS beat(8)-1.96%
EPS beat(12)5
Avg EPS beat(12)-9.88%
EPS beat(16)7
Avg EPS beat(16)-11.1%
Revenue beat(2)0
Avg Revenue beat(2)-7.21%
Min Revenue beat(2)-8.52%
Max Revenue beat(2)-5.89%
Revenue beat(4)1
Avg Revenue beat(4)-3.03%
Min Revenue beat(4)-8.52%
Max Revenue beat(4)4.58%
Revenue beat(8)2
Avg Revenue beat(8)-1.5%
Revenue beat(12)4
Avg Revenue beat(12)-0.62%
Revenue beat(16)7
Avg Revenue beat(16)1.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-600%
EPS NY rev (1m)0%
EPS NY rev (3m)21.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.2
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-1.75
EYN/A
EPS(NY)0.14
Fwd EY3.42%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS17.04
BVpS4.75
TBVpS4.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.17%
ROE -36.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.27%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-8.96%
ROE(3y)-18.73%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.3%
GM growth 5Y-6.23%
F-Score3
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.97%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 0.72
Altman-Z 2.29
F-Score3
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)52.71%
Cap/Depr(5y)60.65%
Cap/Sales(3y)1.49%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.92%
EPS Next Y6.58%
EPS Next 2Y46.06%
EPS Next 3Y37.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.8%
Revenue growth 3Y-9.07%
Revenue growth 5Y-4.34%
Sales Q2Q%-13.51%
Revenue Next Year-3.81%
Revenue Next 2Y0.97%
Revenue Next 3Y1.98%
Revenue Next 5YN/A
EBIT growth 1Y-16.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year228.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-483.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2287.53%
OCF growth 3YN/A
OCF growth 5YN/A